Marshall Wace, LLP Tiziana Life Sciences LTD Transaction History
Marshall Wace, LLP
- $81.7 Billion
- Q2 2025
A detailed history of Marshall Wace, LLP transactions in Tiziana Life Sciences LTD stock. As of the latest transaction made, Marshall Wace, LLP holds 24,369 shares of TLSA stock, worth $40,939. This represents 0.0% of its overall portfolio holdings.
Number of Shares
24,369Holding current value
$40,939% of portfolio
0.0%Shares
1 transactions
Others Institutions Holding TLSA
# of Institutions
34Shares Held
4.62MCall Options Held
0Put Options Held
0-
Dauntless Investment Group, LLC Commerce Township, MI3.42MShares$5.74 Million9.57% of portfolio
-
Ken Griffin Citadel Advisors LLC | Chicago, Il199KShares$334,3030.0% of portfolio
-
Hsbc Holdings PLC London, X0105KShares$177,0130.0% of portfolio
-
Zhang Financial LLC89.8KShares$150,7960.01% of portfolio
-
Susquehanna International Group, LLP Bala Cynwyd, PA86.1KShares$144,6220.0% of portfolio
About Tiziana Life Sciences Ltd
- Ticker TLSA
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 102,273,000
- Market Cap $172M
- Description
- Tiziana Life Sciences Ltd, a biotechnology company, focuses on the discovery and development of molecules to treat human diseases in oncology and immunology. The company's lead product candidate in immunology is Foralumab (TZLS-401), a human anti-CD3 monoclonal antibody (mAb) for the treatment of Crohn's, graft versus host, ulcerative colitis, m...